MDDVF (Medical Developments International) Total Operating Expense: $21.39 Mil (TTM As of Dec. 2025)


MDDVF Medical Developments International Ltd MDDVF
51 GF Score
Price $0.37
GF Value $0.39
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Medical Developments International Total Operating Expense?

Medical Developments International MDDVF 51 Total Operating Expense is $21.39 Mil as of Dec. 2025. GuruFocus rates MDDVF with a GF Score™ of 51/100 and a GF Value™ of $0.39 (Fairly Valued). The stock has 2 warning signs investors should review.

Medical Developments International's Total Operating Expense for the six months ended in Dec. 2025 was $10.55 Mil. Medical Developments International's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was $21.39 Mil.

Medical Developments International Total Operating Expense Related Terms

Medical Developments International Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Medical Developments International's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medical Developments International Total Operating Expense Chart

Medical Developments International Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.03 21.72 28.51 27.38 20.30

Medical Developments International Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.07 11.44 9.21 10.84 10.55
MDDVF
51GF Score
Medical Developments International Ltd MDDVF
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medical Developments International Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $21.39 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $21.39 Mil mean?
Medical Developments International (MDDVF) has a Total Operating Expense of $21.39 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on Medical Developments International and its competitors.
Is Medical Developments International's Total Operating Expense too high?
Medical Developments International's current Total Operating Expense is $21.39 Mil. Overall, Medical Developments International has a GF Score™ of 51/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medical Developments International's Total Operating Expense compare to ZTS and UTHR?
Medical Developments International's Total Operating Expense of $21.39 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Medical Developments International and its competitors. Medical Developments International's current Total Operating Expense is $21.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Developments International stock overvalued right now?
Based on GuruFocus' analysis, Medical Developments International (MDDVF) is currently considered Fairly Valued. The stock's GF Value™ is $0.39, compared to a current price of $0.37 — trading 5.1% below its estimated fair value. The current Total Operating Expense is $21.39 Mil. Medical Developments International's overall GF Score™ is 51/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Medical Developments International (MDDVF), the current Total Operating Expense is $21.39 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medical Developments International (MDDVF) Overvalued in 2026?

Based on GuruFocus' analysis, Medical Developments International stock appears to be undervalued. The current stock price of $0.37 is trading 5.1% below its estimated GF Value™ of $0.39. GuruFocus considers Medical Developments International to be Fairly Valued.

Key valuation signals for MDDVF:

  • Total Operating Expense: $21.39 Mil
  • GF Value™: $0.39 vs. price of $0.37 (5.1% below fair value)
  • GF Score™: 51/100 with 2 warning signs

No single metric tells the full story. See the MDDVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medical Developments International Business Description

Other Exchanges M5D:GermanyMVP:Australia
Address 4 Caribbean Drive, Scoresby, VIC, AUS, 3179
Medical Developments International Ltd is a specialized healthcare company. The Company manufactures and distributes Penthrox, a fast-acting trauma and emergency pain relief product, used in hospital emergency departments, ambulance services, sports medicine, and for analgesia during short surgical procedures. The segments of the company are Pain Management and Respiratory. The company derives maximum revenue from the Pain management segment.
51GF Score

Get the complete analysis for MDDVF

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.37
Price
$0.39
GF Value